(IN BRIEF) The FORESIGHT consortium, comprising leading researchers from UMC Groningen, Amsterdam UMC, NKI/AVL, and TU/e, has launched a pioneering initiative to advance immunotherapy drug development by leveraging molecular imaging and AI technologies. With a grant of at least €9 … Read the full press release →
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged AI, Amsterdam UMC, autoimmune, cardiovascular, clinical studies, Fons van der Sommen, FORESIGHT consortium, Guus van Dongen, Health~Holland, imaging biomarkers, immunotherapy drug development, John Haanen, Liesbeth de Vries, Life Sciences & Health, molecular imaging, neurodegenerative, NKI/AVL, nuclear imaging, oncological, optical imaging, personalized medicine, Peter de With, precision medicine, preclinical studies, Public Private Partnership, Roy van der Meel, TU/e, UMC Groningen, Willem Mulder, €18 million funding, €9 million grant